CL2014001815A1 - Compound 11beta-hydroxysteroid dehydrogenase 1 cyclic compound; pharmaceutical composition; and its use in diseases such as diabetes (div. sol. 2697-11). - Google Patents

Compound 11beta-hydroxysteroid dehydrogenase 1 cyclic compound; pharmaceutical composition; and its use in diseases such as diabetes (div. sol. 2697-11).

Info

Publication number
CL2014001815A1
CL2014001815A1 CL2014001815A CL2014001815A CL2014001815A1 CL 2014001815 A1 CL2014001815 A1 CL 2014001815A1 CL 2014001815 A CL2014001815 A CL 2014001815A CL 2014001815 A CL2014001815 A CL 2014001815A CL 2014001815 A1 CL2014001815 A1 CL 2014001815A1
Authority
CL
Chile
Prior art keywords
compound
11beta
div
sol
diabetes
Prior art date
Application number
CL2014001815A
Other languages
Spanish (es)
Inventor
Martin Renz
Main Schuele
Zhenrong Xu
Original Assignee
Boehringer Ingelheim Int
Vitae Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45478607&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014001815(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2009/002653 external-priority patent/WO2009134400A1/en
Priority claimed from PCT/US2009/004261 external-priority patent/WO2010011314A1/en
Application filed by Boehringer Ingelheim Int, Vitae Pharmaceutical Inc filed Critical Boehringer Ingelheim Int
Publication of CL2014001815A1 publication Critical patent/CL2014001815A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
CL2014001815A 2009-04-30 2014-07-08 Compound 11beta-hydroxysteroid dehydrogenase 1 cyclic compound; pharmaceutical composition; and its use in diseases such as diabetes (div. sol. 2697-11). CL2014001815A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2009/002653 WO2009134400A1 (en) 2008-05-01 2009-04-30 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
PCT/US2009/004261 WO2010011314A1 (en) 2008-07-25 2009-07-23 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1

Publications (1)

Publication Number Publication Date
CL2014001815A1 true CL2014001815A1 (en) 2015-02-13

Family

ID=45478607

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001815A CL2014001815A1 (en) 2009-04-30 2014-07-08 Compound 11beta-hydroxysteroid dehydrogenase 1 cyclic compound; pharmaceutical composition; and its use in diseases such as diabetes (div. sol. 2697-11).

Country Status (10)

Country Link
JP (1) JP5784006B2 (en)
AP (1) AP2011005948A0 (en)
CL (1) CL2014001815A1 (en)
CO (1) CO6501139A2 (en)
HK (1) HK1169409A1 (en)
IL (1) IL215249A (en)
MX (1) MX2011011503A (en)
NZ (1) NZ595473A (en)
PE (1) PE20120794A1 (en)
TN (1) TN2010000467A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2393807B1 (en) * 2009-02-04 2013-08-14 Boehringer Ingelheim International GmbH Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5451611B2 (en) * 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1

Also Published As

Publication number Publication date
NZ595473A (en) 2014-01-31
MX2011011503A (en) 2011-11-18
IL215249A (en) 2014-12-31
IL215249A0 (en) 2011-12-29
HK1169409A1 (en) 2013-01-25
JP2012525440A (en) 2012-10-22
AP2011005948A0 (en) 2011-10-31
TN2010000467A1 (en) 2012-05-24
JP5784006B2 (en) 2015-09-24
PE20120794A1 (en) 2012-07-26
CO6501139A2 (en) 2012-08-15

Similar Documents

Publication Publication Date Title
CL2008001125A1 (en) COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
CL2008001126A1 (en) COMPOUNDS DERIVED FROM PIRIMIDINONE CONDENSED WITH HETEROCICLES; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME AND OBESITY.
IL264316A (en) Stable liquid formulations comprising an antibody to il-1beta, syringes and autoinjectors comprising the same
CL2008002111A1 (en) COMPOUNDS DERIVED FROM PIRIDONA, AGONISTS OF THE RECEPTOR COUPLED TO PROTEIN G GPR119; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DIABETES, METABOLIC SYNDROME, CANCER, AMONG OTHERS.
CL2014002556A1 (en) Compounds derived from indanyloxidihydrobenzofuranylacetic acids, gpr40 receptor agonists; pharmaceutical composition; and its use in the treatment of diseases or conditions such as diabetes, insulin resistance, obesity, among others.
CL2008000690A1 (en) COMPOUNDS DERIVED FROM INDOL-3-PROPIONIC ACID; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA, HYPERTENSION; AMONG OTHER.
CL2008000434A1 (en) COMPOUNDS DERIVED FROM 2-AMINO-OXAZOLINAS; OBTAINING PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS DEPRESSION, ANXIETY, STRESS, BIPOLAR DISORDER, AMONG OTHERS.
BRPI1014034A2 (en) formulation and its use, composition, solution for injection and kit.
EP2718317A4 (en) Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof
IL212605A (en) Cyclic pyrimidin-4-carboxamides and use thereof as medicaments
CL2007002996A1 (en) COMPOUNDS DERIVED FROM REPLACED QUINOLINE, MODULATORS OF LIVER X RECEPTORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS ACUTE CORONARY SYNDROME, ALZHEIMER, DIABETES AND ATEROSCLEROSIS.
PL3517539T3 (en) Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
CL2008000307A1 (en) COMPOUNDS DERIVED FROM CHROMEN-2-ONA REPLACED; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS ATEROSCLEROSIS, ASTHMA, ALLERGIC RHINITIS AND COPD.
CL2013002053A1 (en) Heterocyclic derivative compounds, glucagon receptor antagonists; pharmaceutical composition that includes it and its use in the treatment of diabetes and metabolic diseases. pct
CL2008000791A1 (en) COMPOUNDS DERIVED FROM 2-AMINO-5- (4-DIFLUOROMETOXI-FENIL) -5-FENIL-IMIDAZOLIDIN-4-ONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH EXCESSIVE BACE ACTIVITY, SUCH AS ILLNESS
BR112012017054A2 (en) "oxintomodulin peptide analog, its use as well as pharmaceutical composition"
CL2013002973A1 (en) Compounds derived from substituted phenylglucopyranosyl esters mediators of the sodium / d-glucose co-transporter (sglt); pharmaceutical composition; pharmaceutical combination; and its use in the treatment of metabolic syndrome, x syndrome, diabetes, insulin resistance, among others
CL2007002610A1 (en) COMPOUNDS DERIVED FROM REPLACED BIPIRIDINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PROFILAXIS OF DISEASES SUCH AS HYPERTONIA, DIABETES, MYOCARDIAL INFARTS, BETWEEN OTHERS.
CL2007003879A1 (en) COMPOUNDS DERIVED FROM ARIL-CARBOXAMIDA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ALZHEIMER, EPILEPSY AND PARKINSON.
BRPI1013754A2 (en) Medical module with needle protection.
CL2008000192A1 (en) COMPOUNDS DERIVED FROM PURINA SUBSTITUTED; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS REJECTION TO TRANSPLANTS, LEUKEMIA, DIABETES, AMONG OTHERS.
IL209867A (en) Cyclic peptides, pharmaceutical compositions comprising them and uses thereof as medicaments
BR112012004335A2 (en) compound, pharmaceutical composition, and use of the compound.
PL2419097T3 (en) Pharmaceutical composition comprising (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol and metformin and uses thereof in the treatment of diabetes
BR112012003800A2 (en) composition, peptide, and pharmaceutical formulation.